If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Phase 2 study for people with Huntington's Disease

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Western Sydney Local Health District
Registry number NCT05509153
Started 1 June 2024 Today 16 October 2026 Estimated completion 1 November 2026

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Westmead Hospital Westmead NSW Recruiting
The University of Queensland Herston QLD Not yet recruiting
Calvary Health Care Bethlehem Parkdale VIC Not yet recruiting
The Royal Melbourne Hospital Parkville VIC Not yet recruiting
Perron Institute Nedlands WA Not yet recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 160

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Able to provide informed consent

* Huntingtin gene expansion carrier with \>= 39 CAG repeats

* Absence of unequivocal motor signs of HD - that is, UHDRS

* Diagnostic Confidence Level needs to be \<4 upon enrolment

* Expected to develop clinical HD within 10 years of trial enrolment using the Langbehn formula

* Availability of an informant for corroborative history

* Negative serum pregnancy test for women of childbearing potential

* If of childbearing potential, is able and agrees to remain abstinent or use adequate contraceptive methods

* Ability to tolerate MRI scans

* Ability to tolerate blood draws

* Able to comply with all study protocol requirements, according to the investigators judgement

* In the opinion of the investigator, medically, psychiatrically and neurologically stable at the time of enrolment

Exclusion Criteria:

* Diagnosis of clinical HD

* Known hypersensitivity to NAC

* Pregnancy, breastfeeding or intention to do so prior to the end of the study

* Exposure to any investigational drugs within 30 days of Baseline Visit

* Use of supplemental NAC

* Abnormalities in laboratory measurements, ECG or vital signs at screening, which precludes safe participation in the study

* Current or history of substance abuse within one year of Baseline visit

* Unstable psychiatric or acute medical illness including cancer, as determined by investigator

* Current use of antipsychotic medications or Tetrabenazine

* History of gene therapy, cell transplantation, or any experimental brain surgery

* History of attempted suicide or suicidal ideation within 12 months prior to screening

* Pre-existing structural brain lesion as assessed by a centrally read MRI scan during the screening period

Dates on the record

Started 1 June 2024
Estimated completion 1 November 2026
Registry last updated 28 February 2025
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 28 February 2025.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.